OcellO Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 31

Employees

  • Latest Deal Type
  • M&A

OcellO General Information

Description

Developer of imaging technology designed to visualize and analyze small molecules and biologics through three-dimensional cell culture. The company's technology offers drug screening and profiling models of cancers and other diseases, enabling researchers to easily do imaging and analysis to measure drug effects, extract clinically relevant information on compound effects, and more.

Contact Information

Website
www.ocello.nl
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 21 J.H. Oortweg
  • Leiden BioPartner Center
  • 2333 CH Leiden
  • Netherlands
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Diagnostic Equipment
Biotechnology
Acquirer
Crown Bioscience
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 21 J.H. Oortweg
  • Leiden BioPartner Center
  • 2333 CH Leiden
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OcellO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 05-May-2021 Completed Generating Revenue
4. Later Stage VC Completed Generating Revenue
3. Accelerator/Incubator 06-May-2020 Completed Generating Revenue
2. Angel (individual) 19-Jun-2014 $680K $680K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2009 Completed Startup
To view OcellO’s complete valuation and funding history, request access »

OcellO Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

OcellO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11939394-B2 Binding molecules that inhibit cancer growth Active 23-Oct-2015
US-20180312604-A1 Binding molecules that inhibit cancer growth Active 23-Oct-2015
US-20240343824-A1 Binding molecules that inhibit cancer growth Pending 23-Oct-2015
WO-2017069628-A2 Binding molecules that inhibit cancer growth Inactive 23-Oct-2015
WO-2017069628-A3 Binding molecules that inhibit cancer growth Inactive 23-Oct-2015 C07K16/3046
To view OcellO’s complete patent history, request access »

OcellO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OcellO Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIT Health Accelerator/Incubator
Libertatis Ergo Holding (LEH) Venture Capital Minority
LifeSciences@Work Accelerator/Incubator
To view OcellO’s complete investors history, request access »

Ready to get started?

Request a free trial

OcellO FAQs

  • Where is OcellO headquartered?

    OcellO is headquartered in Leiden, Netherlands.

  • What is the size of OcellO?

    OcellO has 31 total employees.

  • What industry is OcellO in?

    OcellO’s primary industry is Other Healthcare Technology Systems.

  • Is OcellO a private or public company?

    OcellO is a Private company.

  • What is OcellO’s current revenue?

    The current revenue for OcellO is .

  • How much funding has OcellO raised over time?

    OcellO has raised $724K.

  • Who are OcellO’s investors?

    EIT Health, Libertatis Ergo Holding (LEH), and LifeSciences@Work have invested in OcellO.

  • When was OcellO acquired?

    OcellO was acquired on 05-May-2021.

  • Who acquired OcellO?

    OcellO was acquired by Crown Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process